Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026

Go back to Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Asianada, Inc. (NASDAQ: ASND) Delayed: 242.97 +4.07 (1.70%)
Previous Close $238.90    52 Week High $21.79 
Open $239.38    52 Week Low $11.92 
Day High $243.26    P/E N/A 
Day Low $236.87    EPS $-0.07 
Volume 301,210